Oleuropein attenuates the progression of heart failure in rats by antioxidant and antiinflammatory effects

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 390, Issue 3, 2017, Pages 245-252

  Janahmadi, Zeinab ^a,b   Nekooeian, Ali Akbar ^a   Moaref, Ali Reza ^a,c   Emamghoreishi, Masoomeh ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Heart failure; Inflammatory cytokines; Oleuropein; Oxidative stress; Rat

Indexed keywords

GLUTATHIONE REDUCTASE; INTERLEUKIN 1BETA; MALONALDEHYDE; OLEUROPEIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; AUTACOID; BIOLOGICAL MARKER; IL1B PROTEIN, RAT; IRIDOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EFFECT; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE PRESSURE; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; LEFT CORONARY ARTERY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SHAM PROCEDURE; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD; DIAGNOSTIC IMAGING; DISEASE MODEL; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; METABOLISM; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BIOMARKERS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLUTATHIONE REDUCTASE; HEART FAILURE; HEMODYNAMICS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; IRIDOIDS; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 85001578667     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-016-1323-6     Document Type: Article

References (40)

1. Andreadou I et al (2006) The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J Nutr 136:2213–2219
2. Andreadou I et al (2007) Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress. J Mol Cell Cardiol 42:549–558. doi:10.1016/j.yjmcc.2006.11.016
3. Andreadou I et al (2014) Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism. J Mol Cell Cardiol 69:4–16. doi:10.1016/j.yjmcc.2014.01.007
4. Aurigemma GP, Zile MR, Gaasch WH (2006) Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function. Circulation 113:296–304. doi:10.1161/CIRCULATIONAHA.104.481465
5. Bozkurt B, Mann DL, Deswal A (2010) Biomarkers of inflammation in heart failure. Heart Fail Rev 15:331–341. doi:10.1007/s10741-009-9140-3
6. Ertl G, Frantz S (2005) Healing after myocardial infarction. Cardiovasc Res 66:22–32. doi:10.1016/j.cardiores.2005.01.011
7. Ferrari R et al (1998) Oxidative stress during myocardial ischaemia and heart failure. Eur Heart J 19(Suppl B):B2–11
8. Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, Little WC (2001) The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 344:17–22. doi:10.1056/NEJM200101043440103
9. Garjani A, Andalib S, Biabani S, Soraya H, Doustar Y, Maleki-Dizaji N (2011) Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. Eur J Pharmacol 666:135–141. doi:10.1016/j.ejphar.2011.04.061
10. Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115:500–508. doi:10.1172/JCI24408
11. Hegewisch S, Weh HJ, Hossfeld DK (1990) TNF-induced cardiomyopathy. Lancet 335:294–295
12. Huang CL, Sumpio BE (2008) Olive oil, the mediterranean diet, and cardiovascular health. J Am Coll Surg 207:407–416. doi:10.1016/j.jamcollsurg.2008.02.018
13. Huang CX et al (2009) Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 30:2286–2291. doi:10.1016/j.peptides.2009.09.004
14. Janahmadi Z, Nekooeian AA, Moaref AR, Emamghoreishi M (2015) Oleuropein offers cardioprotection in rats with acute myocardial infarction. Cardiovascular toxicology 15:61–68. doi:10.1007/s12012-014-9271-1
15. Keys A (1980) Seven countries: a multivariate analysis of death and coronary heart disease / Ancel Keys, with Christ Aravanis [et al.]. Harvard University Press, Cambridge, Mass
16. Keys A (1997) Coronary heart disease in seven countries. 1970. Nutrition 13:250–252 discussion 249, 253
17. Kim Y, Choi Y, Park T (2010) Hepatoprotective effect of oleuropein in mice: mechanisms uncovered by gene expression profiling. Biotechnol J 5:950–960. doi:10.1002/biot.201000068
18. Klug D, Robert V, Swynghedauw B (1993) Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation. Am J Cardiol 71:46A–54A
19. Kumar D, Lou H, Singal PK (2002) Oxidative stress and apoptosis in heart dysfunction. Herz 27:662–668. doi:10.1007/s00059-002-2430-3
20. Li C, Gao Y, Tian J, Xing Y, Zhu H, Shen J (2012) Long-term oral Asperosaponin VI attenuates cardiac dysfunction, myocardial fibrosis in a rat model of chronic myocardial infarction. Food Chem Toxicol 50:1432–1438. doi:10.1016/j.fct.2012.01.024
21. Mak S, Newton GE (2001) The oxidative stress hypothesis of congestive heart failure: radical thoughts. Chest 120:2035–2046
22. Manna C, Migliardi V, Golino P, Scognamiglio A, Galletti P, Chiariello M, Zappia V (2004) Oleuropein prevents oxidative myocardial injury induced by ischemia and reperfusion. J Nutr Biochem 15:461–466. doi:10.1016/j.jnutbio.2003.12.010
23. McAlpine HM, Morton JJ, Leckie B, Rumley A, Gillen G, Dargie HJ (1988) Neuroendocrine activation after acute myocardial infarction. Br Heart J 60:117–124
24. Menotti A et al (1997) Changes in population cholesterol levels and coronary heart disease deaths in seven countries. Eur Heart J 18:566–571
25. Mercanoglu GO, Pamukcu B, Safran N, Mercanoglu F, Fici F, Gungor M (2010) Nebivolol prevents remodeling in a rat myocardial infarction model: an echocardiographic study. Anadolu Kardiyol Derg 10:18–27
26. Nekooeian AA, Khalili A, Khosravi MB (2014) Effects of oleuropein in rats with simultaneous type 2 diabetes and renal hypertension: a study of antihypertensive mechanisms. J Asian Nat Prod Res 16:953–962. doi:10.1080/10286020.2014.924510
27. Nian M, Lee P, Khaper N, Liu P (2004) Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94:1543–1553. doi:10.1161/01.RES.0000130526.20854.fa
28. Omar SH (2010) Oleuropein in olive and its pharmacological effects. Sci Pharm 78:133–154. doi:10.3797/scipharm.0912-18
29. Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim M (2011) Mechanistic clues in the cardioprotective effect of Terminalia arjuna bark extract in isoproterenol-induced chronic heart failure in rats. Cardiovasc Toxicol 11:48–57. doi:10.1007/s12012-010-9099-2
30. Petroni A, Blasevich M, Salami M, Papini N, Montedoro GF, Galli C (1995) Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Thromb Res 78:151–160
31. Radovanovic S et al (2012) Markers of oxidative damage and antioxidant enzyme activities as predictors of morbidity and mortality in patients with chronic heart failure. J Card Fail 18:493–501. doi:10.1016/j.cardfail.2012.04.003
32. Romero M et al (2016) Antihypertensive effects of oleuropein-enriched olive leaf extract in spontaneously hypertensive rats. Food Funct 7:584–593. doi:10.1039/c5fo01101a
33. Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV (2006) Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol 47:332–337. doi:10.1016/j.jacc.2005.06.088
34. Srikanth G, Prakash P, Tripathy N, Dikshit M, Nityanand S (2009) Establishment of a rat model of myocardial infarction with a high survival rate: a suitable model for evaluation of efficacy of stem cell therapy. J Stem Cells Regen Med 5:30–36
35. Wojciechowska C, Romuk E, Tomasik A, Skrzep-Poloczek B, Nowalany-Kozielska E, Birkner E, Jachec W (2014) Oxidative stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathy. Mediat Inflamm 2014:147040. doi:10.1155/2014/147040
36. Yancy CW et al (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147–e239. doi:10.1016/j.jacc.2013.05.019
37. Zarrouk-Mahjoub S et al (2016) Pro- and anti-inflammatory cytokines in post-infarction left ventricular remodeling. Int J Cardiol 221:632–636. doi:10.1016/j.ijcard.2016.07.073
38. Zarzuelo A, Duarte J, Jimenez J, Gonzalez M, Utrilla MP (1991) Vasodilator effect of olive leaf. Planta Med 57:417–419. doi:10.1055/s-2006-960138
39. Zhang YJ et al (2014) Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy. Clin Exp Pharmacol Physiol 41:995–1002. doi:10.1111/1440-1681.12309
40. Zhou F, Hu SJ, Mu Y (2007) Protection effect of Wenxin Keli on isoproterenol induced heart failure in rats. Zhongguo Zhong Yao Za Zhi 32:1676–1679